FDA Approves New Kind of Drug for Schizophrenia

Published on September 27, 2024

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and. Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they’ve long hoped for: A means of easing the hallucinations…

Read Full Article (External Site)